Nuvasive 

$39.75
3
-$0.91-2.24% Thursday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
2.07B
P/E Ratio
-107.61
Dividend Yield
-
Dividend
-

Earnings

7NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
0.39
0.45
0.5
0.56
Expected EPS
0.5384
Actual EPS
N/A

Financials

3.36%Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
1.2BRevenue
40.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NUVA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
CEO
J. Christopher Barry
Employees
2900
Country
United States
ISIN
US6707041058
WKN
000A0CAYR

Listings

0 Comments

Share your thoughts

FAQ

What is Nuvasive stock price today?
The current price of NUVA is $39.75 USD — it has decreased by -2.24% in the past 24 hours. Watch Nuvasive stock price performance more closely on the chart.
What is Nuvasive stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nuvasive stocks are traded under the ticker NUVA.
What is Nuvasive market cap?
Today Nuvasive has the market capitalization of 2.07B
What is Nuvasive revenue for the last year?
Nuvasive revenue for the last year amounts to 1.2B USD.
What is Nuvasive net income for the last year?
NUVA net income for the last year is 40.41M USD.
How many employees does Nuvasive have?
As of April 18, 2026, the company has 2,900 employees.
In which sector is Nuvasive located?
Nuvasive operates in the Manufacturing sector.
When did Nuvasive complete a stock split?
Nuvasive has not had any recent stock splits.
Where is Nuvasive headquartered?
Nuvasive is headquartered in San Diego, United States.